Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Accounts Payables: 2022-2024

Historic Accounts Payables for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $5.1 million.

  • Orchestra BioMed Holdings' Accounts Payables rose 79.40% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 79.40%. This contributed to the annual value of $5.1 million for FY2024, which is 77.03% up from last year.
  • As of FY2024, Orchestra BioMed Holdings' Accounts Payables stood at $5.1 million, which was up 77.03% from $2.9 million recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Accounts Payables ranged from a high of $5.1 million in FY2024 and a low of $2.9 million during FY2023.
  • Its 3-year average for Accounts Payables is $4.0 million, with a median of $4.0 million in 2022.
  • In the last 5 years, Orchestra BioMed Holdings' Accounts Payables declined by 26.92% in 2023 and then skyrocketed by 77.03% in 2024.
  • Orchestra BioMed Holdings' Accounts Payables (Yearly) stood at $4.0 million in 2022, then declined by 26.92% to $2.9 million in 2023, then skyrocketed by 77.03% to $5.1 million in 2024.